Latest Blogs

Dec 06, 2018
Dr. Colin D. Weekes and the Reverend Joel B. Guillemette had a thoughtful and personal conversation about how they approach deeply challenging questions of hope and mortality in their work following an ASCO town hall event.
Dec 05, 2018
Drs. Arjun Gupta, Erica Nakajima, and Ramy Sedhom offer their personal insights and experience on how to thrive and even appreciate this tough rotation.
Nov 27, 2018
By 2030, the number of deaths due to lung cancer is expected to almost double for Latin American women and increase by 50% for Latin American men.
Nov 20, 2018
 Although there are still several weeks left in 2018, events have left me speechless twice this year: the deaths of two women, well before their time.
Subscribe to this column

Matthew S. Katz, MD

Matthew S. Katz, MD, is the Medical Director of Radiation Oncology at Lowell General Hospital and a partner in Radiation Oncology Associates, PA. He is former Chair of the Communications Committee for the American Society for Radiation Oncology (ASTRO) and External Advisory Board member for Mayo Clinic Center for Social Media. He serves on ASCO's Social Media Working Group, ASTRO's Education Committee, and Massachusetts Medical Society's Communications Committee. His areas of prime interest are patient education and health empowerment. Follow Dr. Katz on Twitter @subatomicdoc.

Nov 15, 2018
During my career, pathologists have always been the “doctor’s doctor.” Why can't they be the "patient's doctor" as well?
Dec 06, 2017
Only 11% of randomized trials give enough detail to practically use in clinical practice. Here are five ways we can use internet-based communication to make it easier for academic innovators to get credit for their work, and  to implement new findings for our patients.
Jul 12, 2017
Here are 10 reasons why we should look at postoperative radiation for regional melanoma.
Jul 19, 2016
Drug companies play a key role in improving cancer care, but financial toxicity for patients continues to worsen. Eternal vigilance is the price of liberty from excessive drug costs, and we have an ethical obligation to hold pharmaceutical companies accountable.
Apr 08, 2016
We have discussed risk, biology, and the importance of complete reporting. So how do we decide to actually use RNI?
Apr 04, 2016
How we report clinical trials makes interpreting their results harder. Why shouldn’t we all have more information to make better decisions for our patients?

Pages